about
Role of plasmacytoid dendritic cells for aberrant class II expression in exocrine glands from estrogen-deficient mice of healthy backgroundAbnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndromeComparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eyeSicca complex among Egyptian patients with chronic hepatitis C virus infection.Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial.Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.Sicca syndrome associated with Tropheryma whipplei intestinal infection.Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndromeAnti-inflammatory effect of peroxisome proliferator-activated receptor-γ (PPAR-γ) on non-obese diabetic mice with Sjogren's syndromeUpregulated expression level of the growth factor, progranulin, is associated with the development of primary Sjögren's syndromeModeling Sjögren's syndrome with Id3 conditional knockout miceXerostomia and the geriatric patient.Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot studyDiagnosing, managing, and preventing salivary gland disorders.Central nervous system mechanisms in Sjögren's syndromeSjogren's syndrome: evolving therapies.Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndromeClinical characteristics and biopsy accuracy in suspected cases of Sjögren's syndrome referred to labial salivary gland biopsy.Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly.Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal aciniParasympathetic nervous system dysfunction in primary Sjögren's syndrome.Cholinergic Autoantibodies from Primary Sjögren's Syndrome Inhibit Mucin Production via Phospholipase C and Cyclooxygenase-2 In the Rat Submandibular Gland.Contribution of IL-13 to early exocrinopathy in Id3-/- mice.Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study.Mouse Models of Primary Sjogren's Syndrome.Xerostomia: clinical aspects and treatment.Temporal bone histopathology and immunoglobulin deposition in Sjogren's syndromeConjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndromeEffect of paeoniflorin on the calcium ion concentration in salivary gland cells using confocal laser scanning microscopy.Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine.Is it safe to use topical NSAIDs for corneal sensitivity in Sjögren's syndrome patients?Peripheral corneal ulceration associated with rheumatoid arthritis.Immune profile of squamous metaplasia development in autoimmune regulator-deficient dry eye.Discrepancies in assessment of patients with rheumatoid arthritis and secondary Sjögren's syndrome by DAS28-ESR and DAS28-CRP.Muscarinic type 3 receptor autoantibodies are associated with anti-SSA/Ro autoantibodies in Sjögren's syndromeDermatologic manifestations of Sjögren syndrome.Oral manifestations and their treatment in Sjögren's syndrome.Medical considerations relating to the oral health of older adults.Non-neuronal functions of the m2 muscarinic acetylcholine receptor.Functional salivary gland regeneration as the next generation of organ replacement regenerative therapy.
P2860
Q24273412-59760B9E-5EE0-4808-9CE5-A072403CE1F7Q24794011-AE9536FC-5551-4D66-B7DE-815B673F6514Q24794134-6A7E2FF6-56FF-4E7C-AFE2-170774457033Q33394887-B49E693D-7A34-4E71-B6F5-16A10800E022Q33543585-A98E2767-6B12-407F-806A-1088324FAEB2Q33884499-1B09090F-E9DB-4D80-AB24-278BC6AFCA24Q33963859-A852C6D5-2F7E-4A8A-86A5-8047FEF7B952Q34086947-2787D6E0-F2DC-43A3-A00F-FF575A4B0CE4Q34121408-3817DF45-4DE1-4073-B231-9F38EF280A7CQ34292351-D32A8304-6259-405F-9F14-6677BD0E205FQ34512394-E674588B-2672-4E44-837A-223A1FD08F8DQ34593888-CF070FBD-E6D5-457D-9C4F-F443A9A58579Q34605699-17BCF238-5613-46D7-8557-39AC652CE906Q34625299-687ED0B2-F8C5-479D-86EA-A32C999833C3Q35051526-F44765EF-0407-4A2D-99A8-95D9CE7A0BABQ35056070-F7CA319D-E5F9-4A38-A10D-2F4018D6ABA6Q35085204-26943EDA-C7C7-4C50-BC53-AABB239E41C0Q35094764-FE275BFC-102F-49E0-A5F3-FB2F968CDBA4Q35135284-F0BEBC0E-5C32-424A-9463-8D77EBB95826Q35140019-0593B7C7-500C-4EE2-8FD5-EDB2486C56D4Q35177776-60B4B3E0-EC67-4E2B-BD65-BC639F98712EQ35224700-ED89014B-72CC-463F-819B-B5DCDE89CA9CQ35488650-50BBEC53-7C07-46EE-B8F2-CDA8B0339A9AQ35552228-AA9911C3-BF52-4FC6-9BCE-34C9BB43AF5CQ35587450-6339DC27-EC88-4C15-9899-97C039D68534Q35617038-C3B53E4A-2C96-4E0D-8E5F-4F5CC518932CQ35685338-D2880804-FF1F-4E29-9CE9-4F22CA6E8EB2Q35769293-D1313C5A-D49E-4C20-BDAB-81B52B501011Q36160114-0188B194-2EFA-4C1A-9B6F-612EE0159AF7Q36269034-5BF60A2E-F1E4-4610-87BC-44FC72715F48Q36689062-97914BBB-BAC6-4173-B282-5660D782FEF3Q37128089-926C221A-36EE-447B-9CE2-AA8E87FB85E7Q37139290-4D6C51F9-78A5-43D6-A076-D9FB939AAA30Q37140622-510371AC-FEAF-4A42-A49E-BD832C4178BEQ37284248-1AFC0A89-B03C-4CC8-A72A-670115F20552Q37835368-C89C4D68-3121-471D-81A9-3B1BDDB7969AQ38096005-79467D2C-1097-40E7-904D-A47DF38B6719Q38116532-112D7B0A-BF87-4C7B-A10F-433D9F7CF411Q38202496-40EE31F7-B158-42BD-82C3-F2DB6631E93AQ38547269-6359C0DD-426D-437A-9EFC-8256AAB97953
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Update in Sjögren syndrome.
@ast
Update in Sjögren syndrome.
@en
Update in Sjögren syndrome.
@nl
type
label
Update in Sjögren syndrome.
@ast
Update in Sjögren syndrome.
@en
Update in Sjögren syndrome.
@nl
prefLabel
Update in Sjögren syndrome.
@ast
Update in Sjögren syndrome.
@en
Update in Sjögren syndrome.
@nl
P2093
P1476
Update in Sjögren syndrome.
@en
P2093
P304
P356
10.1097/00002281-200009000-00007
P577
2000-09-01T00:00:00Z